Valeant Pharmaceuticals International (VRX)

  • NYSE: VRX
  • Mkt.Cap.:2.81B
Focused: Healthcare > Biopharmaceuticals (^BPHRM)

Classification

Sector
Healthcare
Biopharmaceuticals
- Focused
- Sector Pure-Play

Sector companies

Top 5 competitive companies in Biopharmaceuticals (^BPHRM) :

Ticker Name Mkt.Cap.
PFE Pfizer Inc. 143.96B
RHHBY Roche Holding Ltd. (ADR) 141.22B
NVS Novartis AG (ADR) 120.72B
MRK Merck & Co., Inc. 111.76B
GSK GlaxoSmithKline plc (ADR) 98.95B

Relationships

Sample 8 relationships grouped by relationhip type.

Ticker Name
Competitors
Defined by the Company BMY Bristol Myers Squibb Co.
Defined by the Company HGSI Human Genome Sciences
Customers
Defined by the Company CAH Cardinal Health, Inc.
Defined by the Company MCK McKesson Corporation
Suppliers
Defined by the Company NVS Novartis AG (ADR)
Defined by the Company ITMN InterMune, Inc.
Partners
Defined by the Company AGN Allergan, Inc.
Defined by the Company GSK GlaxoSmithKline plc (ADR)
- Defined by the Company
- Defined by Others

Products & Services

Sample products & services from Biopharmaceuticals (^BPHRM) :

  • 8-MOP (Methoxsalen)
  • Ancobon (Flucytosine)
  • Benoquin (Monobenzone)

Relative Performance (1Y)

Relative Chart
  • - Valeant Pharmaceuticals International (VRX)
  • - S&P 500 INDEX (SPX)
  • - Healthcare > Biopharmaceuticals (^BPHRM)

Subscribe to an RSS Feed Research Reports

more »